Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Colorectal Neoplasm Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04001101
What this trial is testing

Anti-PD-1 +/- RT for MSI-H Solid Tumors

Who this might be right for
Microsatellite Instability HighMismatch Repair DeficiencyColorectal Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)Looking for participantsNCT05727163
What this trial is testing

FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 194
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381309
What this trial is testing

Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM

Who this might be right for
CRCLiver Metastasis Colon Cancer
Jun Huang 114
Testing effectiveness (Phase 2)Active Not RecruitingNCT03493048
What this trial is testing

Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM

Who this might be right for
Colorectal CancerLiver Metastases
Sun Yat-sen University 146
Testing effectiveness (Phase 2)UnknownNCT06415851
What this trial is testing

Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab

Who this might be right for
Metastatic Colorectal CancerMSS
Zhangfa Song 36
Testing effectiveness (Phase 2)Study completedNCT01269229
What this trial is testing

A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis

Who this might be right for
Rectal Cancer
Yonsei University 32
Early research (Phase 1)Study completedNCT00972036
What this trial is testing

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 32
Early research (Phase 1)Looking for participantsNCT07066657
What this trial is testing

MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsColorectal CancerGastric Cancer+1 more
ArriVent BioPharma, Inc. 572
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Post-approval studies (Phase 4)Study completedNCT01695772
What this trial is testing

Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 50
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Large-scale testing (Phase 3)UnknownNCT02363049
What this trial is testing

Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer

Who this might be right for
Malignant Neoplasm of Large IntestineColon Cancer Liver Metastasis
Assistance Publique - Hôpitaux de Paris 278
Not applicableStudy completedNCT04517643
What this trial is testing

TheraSphere® For Treatment of Metastases in Liver

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Not applicableStudy completedNCT05468593
What this trial is testing

Patient Outcomes After Hepatic Artery Infusion Pump Placement

Who this might be right for
Colorectal Liver MetastasesColorectal Cancer
Mayo Clinic 12
Large-scale testing (Phase 3)Looking for participantsNCT07221357
What this trial is testing

Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Who this might be right for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb 990
Large-scale testing (Phase 3)Looking for participantsNCT07775287
What this trial is testing

Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)

Who this might be right for
Colorectal Cancer
Genmab 600
Large-scale testing (Phase 3)Not Yet RecruitingNCT07509398
What this trial is testing

FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer

Who this might be right for
Unresectable Colorectal CancerColorectal Cancer (Locally Advanced or Metastatic)
Shanghai 10th People's Hospital 220
Large-scale testing (Phase 3)Study completedNCT04456699
What this trial is testing

Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)

Who this might be right for
Metastatic Colorectal Cancer
Merck Sharp & Dohme LLC 335
Testing effectiveness (Phase 2)Study completedNCT01839877
What this trial is testing

Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study

Who this might be right for
Colorectal Cancer With Non Resectable Hepatic Metastasis
Federation Francophone de Cancerologie Digestive 58
Next Page